the application of jak inhibitors in the treatment of polycythemia vera and myelofibrosis
Published 8 years ago • 336 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
3:48
jak inhibition for the early treatment of myelofibrosis
-
3:52
optimizing the selection between available jak inhibitors in myelofibrosis
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
3:23
myelofibrosis: updates on jak inhibitors
-
4:42
the role of jak inhibitors in treating mpns and the need for disease-modifying agents
-
4:16
jak inhibitor selection & sequencing in myelofibrosis
-
2:45
safety and efficacy of inotuzumab ozogamicin conditioning for allosct in lymphoid malignancies
-
2:04
novel therapies for myelofibrosis patients who have failed jak inhibitors
-
27:23
interactive case: jak inhibitors for the successful management of polycythemia vera
-
3:21
manifest: ruxolitinib plus pelabresib for jak-inhibitor naïve myelofibrosis
-
0:46
xport-mf-034: selinexor plus ruxolitinib in jak-inhibitor naïve myelofibrosis
-
2:37
the role of jak inhibitors in reducing gvhd severity
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
2:07
rationale for jak inhibition in pv
-
1:15
drugs under investigation for patients with mf who have failed treatment with jak inhibitors
-
2:12
refine: phase ii study of navitoclax ruxolitinib in jak inhibitor-naive patients with mf
-
3:21
looking beyond jak inhibitors: novel targeted therapies and strategies for mpn treatment